promising

Andy Cheung Unites Former Binance, OKX, Celsius, Betfair Veterans to Launch AI-Powered Prediction Market

Source Node:
Time Stamp: April 11, 2024 9:24 AM - Modified On: April 11, 2024 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Apr 11, 2024 - (ACN Newswire) - As the crypto world braces for the biggest bull run in history in advance of Bitcoin halving, PredicXion, an innovative financial platform sets to revolutionize the crypto market by integrating AI to navigate and capitalize on the information-rich landscape of 2024. Steering this venture is Andy Cheung, alongside a team with roots in industry giants such as OKX, Binance, Huobi, Celsius, and Betfair. With AI at its core, PredicXion is not merely a platform; it's a comprehensive ecosystem designed to cater

Understanding the Nature of Forex Scams

Source Node:
Time Stamp: April 3, 2024 6:15 AM - Modified On: April 3, 2024 - Published By:
Source Cluster:
Republished By Plato

As the name implies, a scam is a deceptive scheme designed to steal your money. This strategy is not exclusive to any specific industry; it's a real threat even within the trading and financial sectors. Among the numerous scams out there, forex trading scams have gained notoriety. There are many ways these schemes operate, and while the methods may vary, the primary goal remains the same: to rob you of your hard-earned cash. Spotting Scams in an Influencer's Promises One of the most common strategies scammers use includes social media

StakingFarm Introduces a Strategic Blueprint for Crypto Staking Success Amid Market Volatility

Source Node:
Time Stamp: March 20, 2024 8:47 AM - Modified On: March 20, 2024 - Published By:
Source Cluster:
Republished By Plato

  London, England – In an era defined by the digital revolution and the emergence of cryptocurrency as a formidable asset class, StakingFarm is proud to announce its advanced approach to crypto staking, designed to navigate the tumultuous waters of market volatility. This strategic blueprint is not merely a response to the fluctuations inherent in the crypto market; it is a comprehensive guide for investors seeking to maximize their earnings through staking crypto, transforming volatility from a challenge into an opportunity. "Volatility in the crypto market is not a barrier;

Alvara Protocol Raises $2.4M in Lightning Public Round

Source Node:
Time Stamp: March 19, 2024 12:12 PM - Modified On: March 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  Alvara Protocol is looking set to play a substantial role in redefining how the world invests. Their groundbreaking infrastructure, that is set to be an industry first, leverages the ERC-7621 (BTS or Basket Token Standard) to facilitate the creation of fully decentralized tokenized cryptocurrency investment funds. Now, anyone can now become a fund manager with ease. The responsibility for managing funds is something that has long been gatekept. Reserved for institutions or those already financially established. This is no longer the case. Alvara are poised to empower the next

BTC Markets launches major cryptocurrency Immutable X (IMX)

Source Node:
Time Stamp: February 12, 2024 4:39 AM - Modified On: February 12, 2024 - Published By:
Source Cluster:
Republished By Plato

MELBOURNE, February 12, 2024 -- BTC Markets, one of Australia’s leading cryptocurrency exchanges, is proud to announce the addition of prominent cryptocurrency, Immutable X (IMX) to their platform, with the trading pair IMX/AUD launched on 7 February. This listing marks a significant expansion of the exchange’s digital currency offerings. Launched in 2018 by Australians James Ferguson, Robbie Ferguson, and Alex Connolly, Immutable X has garnered significant attention and success globally, showcasing a remarkable 455% price growth in 2023 and achieving a market cap exceeding US$2.7 billion. Recognised as a major

The Challenges and Opportunities behind the Convergence of AI and Blockchain.

Source Node:
Time Stamp: February 1, 2024 1:28 PM - Modified On: February 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Over the last decade, the potential overlap between cryptocurrency and artificial intelligence (AI) — two significant technological trends of the last decade. The curiosity stems from a natural inclination to find a connection between these innovative domains. On the surface, the synergy seems apparent: the decentralizing force of cryptocurrency could offset the centralizing tendencies of AI, while AI's complexity could be made more transparent through blockchain technologies, which are adept at data management and verification. However, the conversation often hit a snag when delving into concrete applications, leading to

Tokens Fueling Innovation in the Dynamic Fantom DeFi Ecosystem

Source Node:
Time Stamp: January 11, 2024 11:52 AM - Modified On: January 11, 2024 - Published By:
Source Cluster:
Republished By Plato

In the rapidly evolving realm of Defi and L1’s, the Fantom ecosystem shines as a vibrant hub for innovation. Within this dynamic landscape, various protocols play pivotal roles in sculpting the future of decentralized finance on Fantom. Each protocol brings its distinct features, vision, and potential to the forefront, propelling growth, stability, and inclusivity within the Fantom DeFi ecosystem. The most known protocol in Fantom is SpookySwap (Ticker : BOO), an EVM-compatible DEX, has been pioneered since its April 2021 launch. Endorsed by the Fantom Foundation and bolstered by community

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Unveiling the Future of Gaming: Gaming Guilds Pioneer the Transition to the Metaverse with TCG World

Source Node:
Time Stamp: October 31, 2023 12:50 PM - Modified On: October 31, 2023 - Published By:
Source Cluster:
Republished By Plato

In a monumental leap towards the future of gaming, we are excited to announce that the world of gaming guilds is undergoing a revolutionary transformation with the advent of the metaverse. This virtual universe, composed of interconnected digital spaces, has opened the doors for gaming guilds to claim their stake in the burgeoning digital economy. With the upcoming launch of TCG World in 2024, the platform is setting the stage for this transformation. TCG World, a virtual world within the metaverse, has successfully registered over 30 gaming guilds with a

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in